TY - JOUR
T1 - Abnormal cardiovascular response to exercise in patients with peripheral arterial disease
T2 - Implications for management
AU - Oka, Roberta K.
AU - Altman, Matt
AU - Giacomini, John C.
AU - Szuba, Andrzej
AU - Cooke, John P.
N1 - Funding Information:
This study was supported in part by grants (J.P.C.) from the National Institutes of Health (R01 HL63685 and PO1AI50153) and the National Institute of Nursing Research (R.O.) (KO1NR00150-01).
Copyright:
Copyright 2011 Elsevier B.V., All rights reserved.
PY - 2005/12
Y1 - 2005/12
N2 - Exercise is beneficial in improving claudication and functional capacity in patients with peripheral arterial disease (PAD). However, the physiologic response during and after exercise testing in this patient population has not been fully described. This study examined the cardiovascular response to exercise and explored the potential contribution of vascular noncompliance to exercise-induced hypertension in 124 patients with PAD and claudication and 31 comparison (C) patients with PAD with no walking limitations. Maximal walking distance was determined by an exercise treadmill test. Heart rate and blood pressure were monitored before, during, and immediately after an exercise test. Vascular compliance of the small and large vessels was measured using pulse waveform analysis. Individuals with low supine resting heart rate had longer pain-free walking distance (r = -0.195, P = .019) and maximal walking versus the C group (62 beats/min, standard deviation [SD] = 10, P = .02). Systolic blood pressure during supine rest was significantly lower for the PAD group (mean = 141 mm Hg, ± SD = 22) versus the C group (mean = 153 mm Hg, ± SD = 20, P = .003). Vascular compliance of large vessels was higher in the C group (mean = 4.13 ± 4.13 mL/mm Hg × 100) compared with the PAD group (mean = 2.95 ± 1.6 mL/mm Hg × 100). This study describes the exaggerated exercise cardiovascular response and impaired vascular compliance in patients with PAD. These results provide further evidence supporting the importance of a monitored treadmill exercise test before initiation of an exercise program to ensure safe and accurate exercise recommendations, and to identify individuals that require more intensive pharmacotherapy to prevent exercise-induced hypertension and tachycardia.
AB - Exercise is beneficial in improving claudication and functional capacity in patients with peripheral arterial disease (PAD). However, the physiologic response during and after exercise testing in this patient population has not been fully described. This study examined the cardiovascular response to exercise and explored the potential contribution of vascular noncompliance to exercise-induced hypertension in 124 patients with PAD and claudication and 31 comparison (C) patients with PAD with no walking limitations. Maximal walking distance was determined by an exercise treadmill test. Heart rate and blood pressure were monitored before, during, and immediately after an exercise test. Vascular compliance of the small and large vessels was measured using pulse waveform analysis. Individuals with low supine resting heart rate had longer pain-free walking distance (r = -0.195, P = .019) and maximal walking versus the C group (62 beats/min, standard deviation [SD] = 10, P = .02). Systolic blood pressure during supine rest was significantly lower for the PAD group (mean = 141 mm Hg, ± SD = 22) versus the C group (mean = 153 mm Hg, ± SD = 20, P = .003). Vascular compliance of large vessels was higher in the C group (mean = 4.13 ± 4.13 mL/mm Hg × 100) compared with the PAD group (mean = 2.95 ± 1.6 mL/mm Hg × 100). This study describes the exaggerated exercise cardiovascular response and impaired vascular compliance in patients with PAD. These results provide further evidence supporting the importance of a monitored treadmill exercise test before initiation of an exercise program to ensure safe and accurate exercise recommendations, and to identify individuals that require more intensive pharmacotherapy to prevent exercise-induced hypertension and tachycardia.
UR - http://www.scopus.com/inward/record.url?scp=28644445721&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=28644445721&partnerID=8YFLogxK
U2 - 10.1016/j.jvn.2005.09.003
DO - 10.1016/j.jvn.2005.09.003
M3 - Article
C2 - 16326331
AN - SCOPUS:28644445721
SN - 1062-0303
VL - 23
SP - 130
EP - 136
JO - Journal of Vascular Nursing
JF - Journal of Vascular Nursing
IS - 4
ER -